ArticleJournal of immunology research2022

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.

Mengqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.